lansoprazole has been researched along with Rectal Neoplasms in 2 studies
Lansoprazole: A 2,2,2-trifluoroethoxypyridyl derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS. Lansoprazole is a racemic mixture of (R)- and (S)-isomers.
Rectal Neoplasms: Tumors or cancer of the RECTUM.
| Excerpt | Relevance | Reference |
|---|---|---|
| "pylori-positive colonic MALT lymphoma but H." | 2.46 | [Regression of MALT lymphoma of the rectum after Helicobacter pylori eradication therapy in a patient negative for Helicobacter pylori]. ( Abue, M; Kon, H; Noguchi, T; Nomura, E; Onodera, H; Ota, Y; Suzuki, M; Suzuki, S; Tateno, H; Uchimi, K, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nomura, E | 1 |
| Uchimi, K | 1 |
| Abue, M | 1 |
| Kon, H | 1 |
| Noguchi, T | 1 |
| Suzuki, S | 1 |
| Suzuki, M | 1 |
| Onodera, H | 1 |
| Tateno, H | 1 |
| Ota, Y | 1 |
| Hisabe, T | 1 |
| Imamura, K | 1 |
| Furukawa, K | 1 |
| Tsuda, S | 1 |
| Matsui, T | 1 |
| Yao, T | 1 |
| Kanda, M | 1 |
| Ohshima, K | 1 |
| Kikuchi, M | 1 |
1 review available for lansoprazole and Rectal Neoplasms
| Article | Year |
|---|---|
[Regression of MALT lymphoma of the rectum after Helicobacter pylori eradication therapy in a patient negative for Helicobacter pylori].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; | 2010 |
1 other study available for lansoprazole and Rectal Neoplasms
| Article | Year |
|---|---|
Regression of CD5-positive and Helicobacter pylori-negative mucosa-associated lymphoid tissue lymphoma of the rectum after administration of antibiotics: report of a case.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Amoxicillin; Anti-Bacterial Agents; CD5 Antigens; Cla | 2002 |